The Cardiac Marker Tests market size was valued at $1.28 billion in 2022. Cardiac Marker testing is used to determine whether levels of specific cardiac markers such as troponin, brain natriuretic peptide (BNP), or creatine kinase – myocardial band (CK-MB) have risen or fallen in suspected and/or existing ACS and HF patients. https://www.globaldata.com/store/report/cardiac-marker-tests-devices-market-analysis/